Lisdexamfetamine

CHEBI:CHEBI_135925

Chemical Information

Molecular Formula
C15H25N3O
Molecular Mass
263.379
Charge
0
SMILES
C([C@@H](NC([C@H](CCCCN)N)=O)C)C1=CC=CC=C1
InChI
InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1
InChIKey
VOBHXZCDAVEXEY-JSGCOSHPSA-N

Alternative Names

  • lisdexamfetamine dimesylate
  • lisdexamphetamine
  • vyvanse

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
700810
oboInOwl#hasDbXref
HMDB:HMDB0015385
core#notation
CHEBI:135925

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
dosage_form
TABLET, CHEWABLE
labeler_name
Euticals, Inc.
application_number
ANDA218604
product_ndc
31722-325
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
700810
oboInOwl#hasDbXref
HMDB:HMDB0015385
oboInOwl#id
CHEBI:135925
generic_name
Lisdexamfetamine dimesylate capsules
brand_name
Vyvanse
brand_name_base
Vyvanse
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#2_STAR
listing_expiration_date
20241231
route
ORAL
marketing_start_date
20180321
spl_id
d22cfada-e644-5af4-e053-2995a90acaca
package_ndc
59116-3010-2
package_description
100 TABLET, CHEWABLE in 1 BOTTLE (31722-324-01)
has_treatment
http://purl.obolibrary.org/obo/DOID_1094
owl#annotatedSource
t108674
owl#someValuesFrom
t3103483
core#notation
CHEBI:135925
rxcui
1871469
manufacturer_name
Mylan Pharmaceuticals Inc.
package_marketing_start_date
21-MAR-18
unii
SJT761GEGS
spl_set_id
0e024b69-567c-4b40-9c3e-a2daec34256c
active_ingredient_strength
18 kg/18kg
dea_schedule
CII
pharm_class
Central Nervous System Stimulation [PE]
active_ingredient_name
LISDEXAMFETAMINE DIMESYLATE
upc
0364850554015
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class